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Better long-term functional adaptation to the child’s size with Renal transplantation (Tx) is the treatment of choice
pediatric compared to adult kidney donors. in children with end-stage renal disease. Although sur-
Background. Pros and cons for pediatric kidney donors have vival rate in transplant children is improving, it is impor-been debated, especially with respect to survival rates. However,
tant to ensure optimal renal function over decades in orderthe effect of donor age on kidney function remains conflicting.
to optimize growth and development. Most major factorsThe aim of this study was to compare short and long-term
renal function according to the age of the donor, in grafts from influencing long-term renal transplant survival have been
adult living related (LRD), adult cadaveric and pediatric cadav- identified through large multicenter analyses [1–3]. The
eric donors (PedCD) following pediatric transplantation (Tx).
pathogenesis of graft dysfunction cannot be explainedMethods. One hundred and thirty-four children were repeat-
only by immunologic phenomena but several antigen-edly followed for four years, and 44 were followed for eight
years. Absolute and relative glomerular filtration rate (GFR; independent risk factors have been demonstrated [4].
inulin clearance, mL/min and mL/min/1.73 m2, respectively) Any kind of donor kidney mass reduction may be one
were determined within 6 months, and yearly thereafter. of these factors, and could result in failure to meet theResults. Absolute GFR increased along with body growth
metabolic demand of the recipient, subsequently leadingin the PedCD group (P  0.001) during the 4 years following
to long-term graft loss. In multicenter series, both graftTx, leading to stable relative GFR, whereas absolute GFR of
the LRD group did not change, with a progressive decrease survival and kidney function were reduced when organs
of relative GFR (P  0.001). Relative GFR did not differ were taken from either very young (10 years of age)
between PedCD and LRD recipients by the sixth month but
or very old donors (70 years of age) compared withbecame higher in PedCD 4 years post-Tx (70  25 vs 52  19
young or middle-aged ones [5]. The best one-year graftmL/min/1.73 m2, P 0.001). Among those followed for 8 years,
relative GFR showed a slow decrease in both recipient groups survival rates were obtained from donors aged 15 to 40
from 6 years post-Tx. At 8 years post-Tx, relative GFR was years [5] and the optimal donor age was defined as 20 to
still significantly higher in PedCD than in LRD (57  19 vs. 25 years by the North American Pediatric Renal Trans-45  19; P  0.05).
plant Cooperative Study [6]. However, recent studiesConclusions. Adult-sized grafts may adapt to pediatric re-
have shown that pediatric donors (10 years of age)cipients during the first months post-Tx, but graft function
cannot improve thereafter along with the increase in body size provided the best long-term graft survival and the lowest
of the recipient. Interestingly, the absolute GFR of children late graft loss rate (abstract; Hardy et al, Pediatr Trans-
receiving pediatric grafts increased along with body growth,
plant 4:105, 2000) [5]. Such good results may be due toleading to a stable relative GFR up to 6 years post-Tx.
a greater number of functioning nephrons compared to
aging kidneys, in which a physiological nephron loss may
occur. Despite a lower graft survival rate at one year,
possibly due to the high risk of vascular thrombosis, the
long-term results were superior, as pediatric transplanted
kidneys may grow in the recipient (abstract; ibid). Thus,Key words: children and transplantation, renal functional adaptation,
pediatric organ donor; adult organ donor; glomerular filtration rate. it seems that both initial mass of the transplanted kidney
and its capacity to adapt to an increasing demand during
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Table 1. Characteristics of patients followed four years post-transplantation (Tx)
Age of the recipient Age of the donor
Number of acute
rejection episodes
mean  SD (range)
Number Number of Type and number during the 1st year
of patients transplants of donor post-Tx (range)
Patients from Stockholm 61 (30 F) 1st  55 All  61 7.85.0 (0.4–17.8)
2nd  6
• CD  15
AdCD  9 10.14.2 (1.8–15.9) 34.013.5 (18.6–62.6) 0.90.8 (0–2)
PedCD  6 5.95.2 (0.4–14.6) 8.13.6 (3.2–11.8) 2.20.8 (1–3)
• LRD  46 7.65.1 (1.1–17.8) 37.27.2 (24.5–55.3) 0.80.8 (0–3)
Patients from Lyon 73 (30 F) 1st  67 All  73 9.84.9 (0.6–18.0)
2nd  3
3rd  3
• CD  57
AdCD  4 12.93.9 (7.7–17.2) 36.07.8 (26.8–45.0) 1.31.3 (0–3)
PedCD 53 9.24.7 (0.7–15.9) 7.14.3 (1.1–16.2) 1.21.1 (0–4)
• LRD  16 9.93.8 (3.2–15.5) 38.04.6 (31.3–49.0) 0.91.0 (0–3)
All patients 134 (60 F) 1st  122 All  134 8.84.8 (0.4–17.8)
2nd  9
3rd  3
• CD  72
AdCD  13 11.04.2 (1.8–17.2) 34.611.7 (18.6–62.6) 1.00.9 (0–3)
PedCD 59 8.84.8 (0.4–15.9) 7.24.2 (1.1–16.2) 1.31.1 (0–4)
• LRD  62 8.24.9 (1.1–17.8) 37.46.6 (24.5–55.3) 0.80.9 (0–3)
F is female.
American series that focused on the evaluation of sur- available in 55 patients, because of graft loss within the
first 6 months post-Tx. All patients with a functioningvival rates and outcome predictive factors, the present
study was conducted in all children with a functioning graft were routinely investigated by renal function tests
performed within 6 months post-Tx and yearly there-graft in two centers to investigate adaptation capacities
of the grafted kidney to the recipient, independent of pa- after. No patient was excluded for medical reasons. One
hundred and thirty four patients were repeatedly fol-tient and graft survival rates. The aim of our study was
to compare short- and long-term renal graft function of lowed for at least four years (Table 1).
Among the 134 patients, 96 had congenital disorders:pediatric recipients in relation to donor age, that is, adult
living related donors (LRD) and adult cadaveric donors 55 malformative uropathies and/or renal hypo/dysplasia,
41 hereditary diseases (nephronophthisis, autosomal re-(AdCD) versus pediatric cadaveric donors (PedCD) in-
dependent of any other known factor, such as HLA- cessive polycystic kidney disease, Finnish-type congeni-
tal nephrotic syndrome, Alport syndrome, cystinosis, Drashmatching, cold ischemia time, number of acute rejection
episodes, etc. syndrome, etc). The remainders suffered from acquired
diseases such as chronic glomerulonephritis (N  19),
focal segmental glomerulosclerosis (N  8), neonatal
METHODS
renal vein thrombosis (N  3), hemolytic uremic syn-
Patients drome (N  7) and miscellaneous disorders (N  1).
Between January 1982 and December 1999, 261 chil-
Immunosuppressiondren and adolescents (108 girls), 104 from Huddinge
University Hospital (Stockholm, Sweden) and 157 from All patients received a standard regimen including
prednisone, azathioprine and cyclosporine. In the Stock-Edouard-Herriot University Hospital (Lyon, France),
received 294 renal transplants. Their mean age was 9.3 holm’s group, cyclosporine was started immediately after
Tx and, in Lyon, induction treatment (rabbit anti-thymo-5.1 (range 0.4 to 18.0) years at Tx. One hundred and
seventy-eight transplants were performed with cadaver cyte globulins) was given and cyclosporine was started
when the serum creatinine value was below 100 mol/L.donors (CD), 36 using AdCD (18 years), 138 using
PedCD (18 years) and 4 whose donor age was un- In Stockholm, cyclosporine dose was adjusted, aiming
at a trough blood level of 300 ng/mL (monoclonal RIA)known, while 116 received a graft from LRD (108 par-
ents, 5 grandparents, 2 aunts, and 1 adult brother). The during the first month, 200 ng/mL during the second
month and 100 ng/mL after three months; the Lyon’sglomerular filtration rate (GFR) assessment was not
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of 0.9% sodium chloride (about 2 mL/kg for 10 min
followed by a continuous infusion of 0.5 or 1 mL/min
depending on the BW). This enabled patients to void by
spontaneous micturition every 30 minutes. Three to four
urine samples were collected and a blood sample was
drawn midway through each collection period. Clearance
values were obtained from the average results of the
three to four periods. Measurements of plasma and urine
polyfructosan were performed using a standard colori-
metric method on an autoanalyzer (AAI; Technicon,
Tarrytown, NY, USA). No significant differences were
found when comparing data of different donor groups
between the two centers. The studies were approved by
the Ethical Committee in both centers.
Statistics
Results are expressed as mean  SD. According to
the parameters, the Student t test and analysis of variance
(ANOVA) for repeated measurements followed by
Scheffe´’s test were used for statistical analysis. The prob-
ability of graft and patient survival according to the type
of donor and center was assessed by the Kaplan-Meier
method followed by a Log rank test. Probabilities of less
than 0.05 were considered to be significant.
RESULTS
The overall five-year patient and graft survival rates
for all 294 Tx were 93 and 78%, respectively. Graft and
patient survival data according to the type of donor are
Fig. 1. Patient and graft survival rates with adult cadaveric donors given in Figure 1. No difference was found between the
(AdCD; - - -), adult living related donors (LRD; - · - ·) and pediatric overall graft and patient survival between the two cen-
cadaveric donors (PedCD; ____). The graft survival rate with LRD is
ters. Only the graft survival rate was significantly highersignificantly higher than with both AdCD and PedCD (*P  0.01).
in the adult LRD group compared with both the AdCD
and PedCD groups (P  0.01).
Independent of donor source, relative GFR at one
group aimed at a trough cyclosporine blood level of 150 and five years post-Tx was 66  22 (N  236) and 58 
to 200 ng/mL during the first six months and 100 to 150 23 (N  118) mL/min/1.73 m2, respectively. The relative
ng/mL thereafter. GFR within six months post-Tx was not significantly
different between LRD (71  25 mL/min/1.73 m2, N 
Methods 104) and PedCD (65  23 mL/min/1.73 m2, N  108),
Three groups of patients were studied: 134 patients nor between PedCD and AdCD (55  27 mL/min/1.73
(59 PedCD, 13 AdCD, 62 LRD), 72 patients (31 PedCD, m2, N 34). The relative GFR of AdCD was significantly
41 LRD) and 44 patients (17 PedCD, 27 LRD) were lower than that of LRD within six months post-Tx, but
tracked over four, six and eight years, respectively. Renal did not differ thereafter.
function was assessed by GFR measurement based on These results were confirmed by sequential assessment
polyfructosan clearance (Inutest, 25%; Laevosan-Gesell- of 134 patients (59 PedCD, 62 LRD and 13 AdCD)
schaft, Wien, Austria). A standard technique was used who were repeatedly tracked over four years post-Tx
with a continuous infusion after a priming dose of poly- (Fig. 2A). In PedCD, absolute GFR and body surface
fructosan 30 mg/kg body weight (BW). Water diuresis area (BSA) increased concomitantly between the sixth
was induced by oral water intake of 20 mL/kg BW during month and the fourth year of follow-up, while the relative
the first hour followed by 5 mL/kg every 30 minutes in GFR did not change significantly. On the other hand,
the Stockholm group; in the Lyon group, an oral water absolute GFR of LRD did not increase along with the
intake of 5 mL/kg BW was given followed by 3 mL/kg child’s growth and relative GFR decreased. Relative
GFR of the PedCD was significantly higher than thoseevery 30 minutes combined with an intravenous infusion
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Fig. 2. Absolute (ml/min; ) and relative (ml/min/1.73 m2; ) GFR and body surface area (BSA m2; ) of the children who received a graft from
a pediatric cadaveric, a living related or an adult cadaveric donor. Data are mean  SD. The patients were investigated exhaustively over the 4
(A), 6 (B) and 8 (C ) years post-transplantation. The absolute GFR improved significantly in the pediatric group (P  0.0001) during the 4 and 6
years post-transplantation. However, the absolute GFR of living related donor group remained unchanged despite growth, so that relative GFR
decreased (P  0.0001). Note that BSA increased significantly in the 2 groups (P  0.0001). Stars show intervals that are significantly different
from the first assessment (Scheffe´’s test, P  0.05).
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of both AdCD and LRD from the first to the fourth GFR approximated 60 mL/min/1.73 m2 during the first
five years post-Tx, which is comparable with other expe-years. Similar changes were noted in recipients of 31
PedCD and 41 LRD followed over six years (Fig. 2B). riences [15–18]. As shown by Gellert et al, relative GFR
in adult donor groups (AdCD and LRD) was not dif-In addition, the relative GFR of PedCD was significantly
higher than that of LRD from the second to the sixth ferent from the PedCD group at six months post-Tx,
probably as a result of an adaptation of the graft functionyear after Tx.
The sequential assessment of 17 PedCD and 27 LRD to the recipient requirements [15]. Conversely, the rela-
tive GFR of LRD is higher than GFR of AdCD only atover eight years showed two different profiles along with
time (Fig. 2C): (1) an improvement of absolute GFR of six months post-Tx. This was previously shown by Sei-
kaly et al, who concluded that GFR was higher in allo-PedCD and a stability of relative GFR during the first
four-year period, and (2) a decrease in relative GFR of grafts from LRD compared to CD kidneys only in the
first 12 months following Tx, but the age of the donorsdonor source (PedCD or LRD) during a second period
of time, due to the lack of change in absolute GFR was unknown [19].
The capacity of the kidney graft to adapt could bedespite body growth. After eight years, the relative GFR
of PedCD was still higher than that of LRD (57  19 evaluated by sequential assessment of GFR of patients
exhaustively analyzed during four, six or eight years.vs. 45  19 mL/min/1.73 m2, P  0.05).
The absolute GFR of pediatric graft recipients improved
significantly during the first six years post-Tx. As shown
DISCUSSION
in Figure 2 A and B, sequential absolute GFR measure-
In large European and North American series, the ments correlated positively with BSA, which increased
one- and five-year graft survival rates of children after as the children grew. An increase in absolute GFR on
renal Tx have dramatically improved up to 80 and 65%, follow-up suggests that there is a significant reserve ca-
respectively [7–9], with the best rates being observed pacity for growth and/or compensatory hypertrophy in
after living-related donation [10]. Our current study the transplanted kidney from a pediatric donor. Provoost
found that the overall one- and five-year graft and patient et al demonstrated both in rats and humans receiving
survival rates are comparable to other series, and the grafts from donors of unequal body size that the function
graft survival rate is significantly better with LRD than of the transplanted kidney adapted to the body size of
with CD. the recipient [20]. Offner et al speculated that such an
The aim of renal replacement therapy during child- adaptation is limited with a nadir kidney function six
hood is to restore their potential for normal growth and weeks after Tx when the donor was less than 10 years
development, in order to reach optimal final height. A old [21].
graft therefore must provide good renal function over a When evaluating kidney function in the child recipient
long period of time to allow adequate growth [11, 12]. and the adult living donor simultaneously within five to
The outcome of pediatric renal Tx is influenced by six months after Tx, Bohlin and Berg [22] and Berg,
numerous factors. The role of the donor source on the Bohlin and Tyde´n [23] showed that while the absolute
long-term renal function outcome has not been exten- GFR of the recipient was significantly lower than that
sively studied and remains controversial. The number of of the donor, the relative GFR did not differ. They con-
grafts from PedCD, LRD or AdCD depends more on cluded that the absolute GFR of the recipient was di-
local convenience and cultural background than on ratio- rectly related to the size (BSA) of the recipient with a
nale from clinical trials. We therefore collected data from functional adaptation of the adult graft to the small size
the departments of pediatrics in Huddinge University of the recipient. In the present study, sequential determi-
Hospital (71% LRD, 13% PedCD and 16% AdCD) and nation of GFR started three to six months post-Tx and
in Lyon University Hospital (18% LRD, 70% PedCD absolute GFR of patients receiving LRD grafts did not
and 10% AdCD), two centers using comparable immu- change over the six and eight years post-Tx despite the
nosuppression protocols and prospective renal function child’s growth. As a result the relative GFR decreased
monitoring. The aim of the study was to compare renal significantly, as previously noticed by Qvist et al, who
function of transplanted kidneys with respect to the type found a slow decrease in relative GFR in both LRD and
and age of the donor (that is, PedCD, AdCD and LRD), CD donors, with an age of approximately 28 years in
independent of any other known factors. Both centers CD donors [24]. These results suggest that, following an
have previously reported part of their results in a limited initial adaptation of the adult-sized kidney to the small
number of patients [13, 14]. Other known factors—such size of the recipient [22, 23], the graft cannot experience
as HLA-matching, cold ischemia time, number of acute a long-term adaptation to the increasing requirement of
rejection episodes—are comparable between the two the growing child. Such a functional adaptation may be
groups, and suggest LRD as a favored donor source. due to reduced renal blood flow in the graft because of
a low cardiac output of the pediatric recipient leadingIndependent of the duration of follow-up, the overall
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to ischemic damage to the kidney and subsequent limita- rate as adult donor recipients. Many studies have claimed
tion in absolute GFR increase. On this basis, Sarwal that renal mass of the graft is essential in the long-term
et al recommended an aggressive assisted fluid support renal function outcome. We still have to question the
during the first 6 to 12 months post-Tx in infants in order significance of renal mass: is renal weight or functioning
to allow optimal perfusion of the size-discrepant adult nephron number the main determinant? Does the pedi-
sized kidneys (abstract; Pediatr Transplant 4:105, 2000). atric graft have the capacity to respond to growth factors
In children who were traced for eight years after Tx, that are lacking in an adult kidney graft?
GFR showed a slow decrease independent of the donor
source, LRD or PedCD. Sorof et al showed that the ACKNOWLEDGMENTS
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